Redhill Capital

Guangna Development is a producer of micro-nano optics technology designed to improve traditional geometric optical display solutions.

Inflamax Pharmaceuticals is a biomedical technology company that specializes in the innovation and development of immune-inflammatory drugs.

Douli is an employee service platform that provides welfare solutions for enterprises. They offer services in the fields of clothing, food, housing, transportation, medical care, entertainment, and more by combining online and offline multi-channel resources.

Huizhengqi Medicine is a pharmaceutical company that develops mRNA drugs for the treatment of tumor and immunity diseases.

Xianwei Medical is a manufacturer of ophthalmic surgical robots. It focuses on the field of ophthalmic surgical robots, promoting the product finalization and inspection of the third-generation ophthalmic surgical robots while also starting the medical treatment of other product pipelines under research, such as dry eye treatment equipment.

ZD MedTech specializes in developing advanced robotic assistive technology and intelligent rehabilitation solutions tailored for clinical needs in China. The company's core offerings include high-end rehabilitation robots and exoskeleton upper limb training robots, designed to enhance patient recovery and expedite rehabilitation treatment.

Huawei Hengyuan is a biomedical technology company dedicated to the preparation of Sertoli cells (with immune immunity) in vitro using cell reprogramming technology, mainly for: autoimmune diseases (such as rheumatoid arthritis); reproductive adjuvant therapy; human body Chronic diseases (such as Parkinson's); organ/tissue colonization (such as skin allograft).

Precision Autoimmune Therapeutics is a clinical-stage innovative drug development company focused on precision therapeutics for patients with autoimmune and inflammatory diseases.

Metanovas Biotech is a company focused on developing innovative nutraceutical and cosmeceutical products using advanced artificial intelligence technology. Their product pipeline encompasses pharmaceuticals, nutritional supplements, functional foods, and cosmetics, aimed at enhancing the health and well-being of patients and consumers. Metanovas employs a sophisticated AI-enabled platform for drug and disease discovery, utilizing machine learning to identify novel disease targets, screen potential drugs, and repurpose existing medications for new applications. This approach allows for optimized drug development and improved insights into disease biology, ultimately leading to the creation of more effective health products.

SensView is a company focused on the development and production of solid-state imaging chips and detector modules. Its primary offerings include CMOS flat panel detectors and a range of X-ray detectors, such as computed tomography detectors and photon counting detectors. SensView utilizes advanced monocrystalline silicon technology to create these imaging solutions, which are designed to support various industrial applications. Through its innovative products, SensView aims to enhance imaging capabilities across multiple sectors.

Vibrant develops an AI drug development platform to focus on building immune system-related drug pipelines. The company will use artificial intelligence algorithms to accelerate the efficiency of drug development in various aspects such as target discovery, drug design, and drug efficacy evaluation; at the same time, the company expects to continuously improve the success rate of drug development through sustainable data accumulation and algorithm optimization. It was founded and headed by Dr. Wang Luquan and is based in Guangzhou, Guangdong, China.

Lecheng Cloud Service is a cloud SaaS insurance platform that provides internet and online insurance service plans.

Xinji Pharmaceuticals is mainly engaged in the R&D of new drug preparations and drug release systems. The company is especially involved in the application and promotion of drug-controlled release, sustained release, and targeted drug release technologies in the industrialization of biomedicine.

Manteia Technology is a radiology systems company established in 2017 and headquartered in Xiamen, China, with a wholly-owned subsidiary in the United States. The company specializes in developing advanced radiotherapy solutions for cancer treatment, leveraging deep learning, data technology, and traditional algorithms. Manteia's research and development teams, which comprise approximately 50 professionals, including a significant proportion of doctors and master's degree holders, are dedicated to creating innovative software for automatic target volume delineation, dose calculation, and intelligent adaptive radiotherapy systems. The company's expertise is evidenced by over 170 published scientific papers in radiotherapy, along with 26 software copyrights, 2 international patents, and 6 domestic patents. Manteia has received recognition as a "Double Hundred Talents" enterprise by the Xiamen Municipal Government and has garnered strategic investments from notable organizations in the radiotherapy sector.

SensView is a company focused on the development and production of solid-state imaging chips and detector modules. Its primary offerings include CMOS flat panel detectors and a range of X-ray detectors, such as computed tomography detectors and photon counting detectors. SensView utilizes advanced monocrystalline silicon technology to create these imaging solutions, which are designed to support various industrial applications. Through its innovative products, SensView aims to enhance imaging capabilities across multiple sectors.

Meibai bio focuses on the R&D, production & sales of biological scaffold material for maxillofacial tissue regeneration for medical and medical plastic and cosmetic clinical needs.

Suzhou Liangyihui Network Technology Co., Ltd. is an authoritative anti-cancer academic platform based in Shanghai, China. The company focuses on addressing the information asymmetry prevalent in the oncology field by fostering long-term collaborations with various well-known hospitals and authoritative institutions both domestically and internationally. Liangyihui operates an online platform that provides comprehensive educational materials related to tumor treatment and oncology. This includes medical cases, conference information, online courses, and research reports, all aimed at offering reliable information and resources for oncologists, cancer researchers, and patients. The platform serves as a vital tool for promoting cancer prevention and treatment, thereby enhancing public awareness and understanding of cancer-related issues.

Juventas is a developer of innovative immune cell therapeutic drugs aimed at treating malignant hematological neoplasms, including leukemia and lymphoma. The company has had its first investigational new drug application for the cell therapeutic product CNCT19 accepted by the National Medical Products Administration. Juventas is committed to developing a comprehensive product pipeline that focuses on advancing immune cell therapies and accelerating innovation in this field, thereby providing effective treatment options for patients suffering from these serious conditions.

Suzhou Liangyihui Network Technology Co., Ltd. is an authoritative anti-cancer academic platform based in Shanghai, China. The company focuses on addressing the information asymmetry prevalent in the oncology field by fostering long-term collaborations with various well-known hospitals and authoritative institutions both domestically and internationally. Liangyihui operates an online platform that provides comprehensive educational materials related to tumor treatment and oncology. This includes medical cases, conference information, online courses, and research reports, all aimed at offering reliable information and resources for oncologists, cancer researchers, and patients. The platform serves as a vital tool for promoting cancer prevention and treatment, thereby enhancing public awareness and understanding of cancer-related issues.

Meibai bio focuses on the R&D, production & sales of biological scaffold material for maxillofacial tissue regeneration for medical and medical plastic and cosmetic clinical needs.

Vistel is a technology company established in 2016 by Sun Yuhui and Ding Dayong, specializing in artificial intelligence applications within the medical field. The firm develops AI-driven ophthalmic medical imaging technology designed to enhance the diagnosis of eye diseases. By employing advanced diagnostic systems that utilize computer vision processing and sophisticated image annotation, Vistel aims to provide medical practitioners with the tools necessary to digitally analyze and manage patients' ocular conditions effectively.

Vibrant develops an AI drug development platform to focus on building immune system-related drug pipelines. The company will use artificial intelligence algorithms to accelerate the efficiency of drug development in various aspects such as target discovery, drug design, and drug efficacy evaluation; at the same time, the company expects to continuously improve the success rate of drug development through sustainable data accumulation and algorithm optimization. It was founded and headed by Dr. Wang Luquan and is based in Guangzhou, Guangdong, China.

GenAssist Therapeutics, founded in July 2020 by a team of leading scientists and industry experts, specializes in the development of gene therapy drugs utilizing advanced base editing technology. The company is focused on addressing neuromuscular diseases that currently lack effective treatments, particularly Duchenne Muscular Dystrophy (DMD) and Spinal Muscular Atrophy (SMA). GenAssist aims to provide permanent cures by precisely repairing disease-causing genes directly within patients' cells. The company holds global intellectual property rights to its proprietary Targeted AID-based Mutagenesis (TAM) technology, positioning it at the forefront of innovative solutions for a range of genetic disorders.

Cofoe is a medical device company that focuses on providing comprehensive healthcare solutions. The company offers a range of products including healthcare monitoring devices, rehabilitation aids, respiratory support systems, traditional Chinese medicine tools, medical care equipment, and hearing solutions. Cofoe's portfolio includes several brands: Jianer Hearing, which provides extensive hearing solutions; Good Nurse Medical Devices, specializing in the omnichannel retail operation and management of medical devices; Keyuan Medica, which operates a one-stop medical device supply chain platform; and Youngleda, known for developing portable oxygen generators and related consumables.

PandaMed, officially known as Changzhou Zhishan Medical Technology Co., Ltd., is a high-tech company established in May 2017, dedicated to the research, development, and industrialization of non-invasive medical devices focused on diabetes and weight loss. Headquartered in the West Taihu Hi-Tech Industrial Park in Changzhou, the company was founded by a team of domestic and international medical experts and experienced practitioners in the medical equipment field. PandaMed specializes in developing solutions for obese patients, offering services that include an intragastric balloon system and comprehensive health management. The company also has a research and development center located in Shanghai, further enhancing its capacity for innovation in chronic disease treatment and non-invasive weight loss solutions.

Suzhou Liangyihui Network Technology Co., Ltd. is an authoritative anti-cancer academic platform based in Shanghai, China. The company focuses on addressing the information asymmetry prevalent in the oncology field by fostering long-term collaborations with various well-known hospitals and authoritative institutions both domestically and internationally. Liangyihui operates an online platform that provides comprehensive educational materials related to tumor treatment and oncology. This includes medical cases, conference information, online courses, and research reports, all aimed at offering reliable information and resources for oncologists, cancer researchers, and patients. The platform serves as a vital tool for promoting cancer prevention and treatment, thereby enhancing public awareness and understanding of cancer-related issues.

Mingyitang Hospital is a traditional medicine clinic operator.

Juventas is a developer of innovative immune cell therapeutic drugs aimed at treating malignant hematological neoplasms, including leukemia and lymphoma. The company has had its first investigational new drug application for the cell therapeutic product CNCT19 accepted by the National Medical Products Administration. Juventas is committed to developing a comprehensive product pipeline that focuses on advancing immune cell therapies and accelerating innovation in this field, thereby providing effective treatment options for patients suffering from these serious conditions.